Heartburn News and Research RSS Feed - Heartburn News and Research

Heartburn, also know as acid reflux, is a painful and burning sensation in the esophagus, just behind the breastbone usually associated with regurgitation of gastric acid (gastric reflux).
Research highlights potential of computers to enhance quality of care, medical outcomes

Research highlights potential of computers to enhance quality of care, medical outcomes

A computer system was more effective than doctors at collecting information about patient symptoms, producing reports that were more complete, organized and useful than narratives generated by physicians during office visits, according to a Cedars-Sinai study. [More]
Good first aid kit can help make your vacation perfect

Good first aid kit can help make your vacation perfect

Planning a vacation? Make a little room in your luggage for a travel first aid kit. It won't cost much, and it won't take up much space. Once you reach your destination, you won't need to reach any further than your suitcase to relieve those minor aches and pains that can put a major damper on your plans. [More]
Women delay seeking medical care for heart symptoms, put health at risk

Women delay seeking medical care for heart symptoms, put health at risk

When heart symptoms strike, men and women go through similar stages of pain but women are more likely to delay seeking care and can put their health at risk, according to a study presented at the Canadian Cardiovascular Congress. [More]
CHOP joins CEGIR to advance treatment of eosinophilic disorders

CHOP joins CEGIR to advance treatment of eosinophilic disorders

The Children's Hospital of Philadelphia has joined a new consortium announced today by the National Institutes of Health to advance the treatment of chronic inflammatory diseases called eosinophilic disorders. [More]
State highlights: States and drug prices; Ariz. limiting Sovaldi for patients; L.A. boosts uninsured care by $61 million

State highlights: States and drug prices; Ariz. limiting Sovaldi for patients; L.A. boosts uninsured care by $61 million

Because of its high cost, some state Medicaid programs and prison systems are refusing to provide Sovaldi to any but the sickest patients. Most recently, Oregon last month threatened to limit access to the drug unless it can get Sovaldi at a deeply discounted price. But Sovaldi is only the beginning. Expensive new treatments for certain cancers, rheumatoid arthritis and other conditions also have rattled Medicaid officials, patients and health care providers. What can states do to hold down drug costs? Drug pricing is a complicated and opaque process. [More]
Researchers examine role of blocking vagus nerve in weight loss

Researchers examine role of blocking vagus nerve in weight loss

Among patients with morbid obesity, blocking the vagus nerve, which plays a role with appetite and metabolism, did not meet pre-specified efficacy objectives compared to a control group, although the intervention did result in greater weight loss, according to a study in the September 3 issue of JAMA. [More]
Feds to withhold some doctor payment data after inconsistencies

Feds to withhold some doctor payment data after inconsistencies

The Centers For Medicare & Medicaid Services said Friday that, because of data inconsistencies, a third of the records in a database showing drug and device-maker contributions to doctors will be withheld next month when the website goes live. [More]
First Edition: August 18, 2014

First Edition: August 18, 2014

Today's headlines stories about the pervasive nature of Medicare fraud and the difficulties involved in fighting it. [More]
Highlights: Texas abortion rates falls dramatically; start-up problems for Virginia's psychiatric reforms

Highlights: Texas abortion rates falls dramatically; start-up problems for Virginia's psychiatric reforms

A four-month-old psychiatric-bed registry that is supposed to provide up-to-the-minute information for Virginians who need emergency mental health treatment is being updated as seldom as once a day, state officials told a panel of lawmakers this week (Shin, 7/22). [More]
First Edition: July 24, 2014

First Edition: July 24, 2014

Today's headlines include more analysis of this week's conflicting appeals courts' decisions regarding a key part of the health law. [More]
Statins reduce patient's risk of developing Barrett's esophagus

Statins reduce patient's risk of developing Barrett's esophagus

Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. [More]
RD Biomed announces Chinese distribution agreement for reflux diagnostic tool Peptest

RD Biomed announces Chinese distribution agreement for reflux diagnostic tool Peptest

RD Biomed, the Yorkshire medical technology company, has announced a Chinese distribution agreement for its world-leading reflux diagnostic tool Peptest. [More]
LINX Reflux Management System safe for patients suffering from GERD, shows new data

LINX Reflux Management System safe for patients suffering from GERD, shows new data

Torax Medical today announced the release of new data from two leading U.S. medical centers that further establishes the LINX Reflux Management System as a safe and effective procedure for patients suffering from gastroesophageal reflux disease (GERD). [More]
Generic drug delays cost U.S. payers millions

Generic drug delays cost U.S. payers millions

Problems surrounding an Indian company's launch of generic versions of three blockbuster drugs have preserved millions in revenue for the brand-name makers, reports The Wall Street Journal. [More]
First Edition: June 18, 2014

First Edition: June 18, 2014

Today's headlines include a report that the cost of health law subsidies may push the measure's overall price tag beyond projections. [More]
C-section delivery, early antibiotic treatment linked to eosinophilic esophagitis in children

C-section delivery, early antibiotic treatment linked to eosinophilic esophagitis in children

Children delivered by cesarean section and those given antibiotics during early infancy appear more prone to developing allergic inflammation of the esophagus — the muscular tube that connects the mouth to the stomach — according to results of a study by investigators from the Johns Hopkins Children’s Center and Harvard Medical School. [More]
FAST Upset Stomach offers one shot dose of Liquid Relief for people suffering from heartburn

FAST Upset Stomach offers one shot dose of Liquid Relief for people suffering from heartburn

First Aid Shot Therapy, makers of First Aid Shot Therapy Pain Relief, today announced the launch of its newest offering, First Aid Shot Therapy Upset Stomach. Upset Stomach is the second variant to be launched in the F.A.S.T. range of products and it is formulated to relive upset stomach symptoms. [More]
Study confirms safety of LINX Reflux Management System for GERD treatment

Study confirms safety of LINX Reflux Management System for GERD treatment

Millions of Americans suffer from Gastroesophageal Reflux Disease (GERD), a chronic, often progressive disease that can cause debilitating symptoms and lead to serious complications including pre-cancerous Barrett's esophagus and esophageal cancer. [More]
Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

Today the U.S. Food and Drug Administration (FDA) approved over-the-counter Nexium® 24HR (esomeprazole 20mg) marking a key step towards providing those who suffer from frequent heartburn broader access to a brand doctors and patients have trusted for years. [More]

Ironwood Pharmaceuticals starts Phase IIa clinical study of IW-3718 for gastroesophageal reflux disease

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has begun in its Phase IIa clinical study of its investigational compound IW-3718 in patients suffering from gastroesophageal reflux disease (GERD) who have not responded adequately to treatment with a proton pump inhibitor (PPI). Data are expected in the first half of 2015. [More]